Charles Albright, Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 20,000 shares at $35.98 ($720K) on 2018-06-13, disclosed to the SEC on 2018-06-15.
Open-market sale of $720k EDIT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.98 | 10,000 | $360K | 50.0% |
| 2 | $35.98 | 10,000 | $360K | 50.0% |
| Total | $35.98 avg | 20,000 | $720K | 100% |
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |